ALS Therapy Development
Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Building on progress made in 2010, the MDA-supported ALS TDI has outlined a number of milestones it plans to meet in 2011
Posted on Thursday, February 10, 2011 - 10:54, By: Amy Madsen
New space for research, new mouse models of ALS and new technology to screen therapeutic agents all will play a role in 2011 at the ALS Therapy Development Institute (ALS TDI), said Steve Perrin, ALS TDI chief scientific officer and CEO, in the biotech's monthly webinar in January.